Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Filter News
Show All Results
News By Country
News By Tag
Biotechnology Remove
Related Tags


December 2014
Th We Tu Mo Su Sa Fr
25 24 23 22 21 20 19

biotechnology Press Releases

  + XML/RSS  



By Eulysis
Eulysis Raises $3.2 Million to Launch the Single Vial System (SVS)

By NuVascular Technologies, Inc.
Medical Device Company Cited for Breakthrough Electrospinning Platform Technology, Which Has a Large Variety of Applications

By Molekule Consulting, Inc.
Molekule consulting, Inc. to sponsor & exhibit at the 2015 Pharma CI Europe Conference & Exhibition. Molekule President, David Alderman, to speak on key competitive intelligence topic

By New Amsterdam Genomics
October 2nd, 2014, (New York, NY) - New Amsterdam Genomics and Prodigo Solutions today announced a partnership that will allow Prodigo Solutions to offer NAG’s revolutionary Genomic sequencing and analysis platform through their digital catalogue,...

By Pathology Diagnostics Ltd
Pathology Diagnostics Ltd is one of the earliest SME recipients of the £180 million Technology Strategy Board (the UK’s Innovation Agency) Biomedical Catalyst funding programme; winning a Biomedical Catalyst feasibility award in the second round.

By Vasuda Capital Management
Vasuda Capital Management, LLC, a Greater Boston-based investment firm, announced that its funds and managed accounts outperformed the S&P 500 index in August 2014 (up 17.6% vs. 3.7%).

By Amyndas Pharmaceuticals
Amyndas Pharmaceuticals SA, the complement therapeutics company, announced that the European Medicines Agency (EMA) has granted AMY-101, a potent complement C3 inhibitor, an Orphan Drug Designation for the treatment of Paroxysmal Nocturnal Hemoglobinuria.

By national algae association
Commercially-minded algae researchers working together with private industry for job training and new business opportunities.

By iGEM
iGEM will host the largest annual gathering of synthetic biologists worldwide at the collegiate division’s Giant Jamboree, October 30 - November 3, 2014
in Boston, Massachusetts.

By UK Shared Business Services Ltd & GATC Biotech Ltd
For three consecutive times GATC Biotech is awarded the DNA sequencing tender by UK Shared Business Services Ltd (UK SBS)

By Mary Ann Liebert, Inc., publishers
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc, (914) 740-2100, kruehle@liebertpub.com Novel Methods May Help Stem Cells Survive Transplantation into Damaged Tissues New Rochelle, NY—Stem cells offer much promise for treating damaged organs and...

By Mary Ann Liebert, Inc., publishers
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc, (914) 740-2100, kruehle@liebertpub.com New Research from Africa on Pharmacomicrobiomics New Rochelle, NY—The Human Microbiome Project (HMP) is a global initiative to identify and characterize the...

By Mary Ann Liebert, Inc., publishers
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc., (914) 740-2100, kruehle@liebertpub.com NIH Turns to Crowdsourcing to Repurpose Drugs: Initial Success Exceeds Expectations New Rochelle, NY–Experimental drugs proven safe but perhaps not sufficiently...

By Information Mapping
With structured HR policies, procedures and other documentation, you can say goodbye to the problems caused by unclear communication. Structured documentation puts you in control of your information.

By Ariel Fernandez Consultancy
Protein structural defects are key players in enzyme catalysis

By Pathology Diagnostics Ltd
Senior technical management staff from Pathology Diagnostics attended the recent DakoLink-UP Scientific Symposium held in York in June 2014.

By Pharma CI Conference
The Pharma CI Asia Conference is the premier event for getting the best information from industry experts (pharmaceutical competitive intelligence), while also providing a unique environment to have meaningful dialogue among peers.

By SMi Group
Join SMi Group's 2nd annual Lyophilisation forum taking place on 7-8 July, London, and gain insight into current successes and challenges that leading pharmaceutical and biotechnology organisations are facing during their lyophilisation life cycles.

By Transparency Market Research
Orthobiologics Market (Allografts, Viscosupplements, DBM, BMP, Stem Cell and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

By Genetic Engineering and Biotechnology News
Contact: Tamlyn Oliver, Managing Editor, Ph. 914-740-2199, toliver@clinicalomics.com GEN Publishing Introduces “Clinical OMICs” Digital Publication New Rochelle, NY—GEN Publishing recently introduced “Clinical OMICs,”...

All Press Releases

By Eulysis
Eulysis Raises $3.2 Million to Launch the Single Vial System (SVS)

By Creative Biolabs
Humanization is significant for reducing the immunogenicity of monoclonal antibodies derived from rodent sources and for improving their activation of the human immune system.

By NuVascular Technologies, Inc.
Medical Device Company Cited for Breakthrough Electrospinning Platform Technology, Which Has a Large Variety of Applications

By Life Science Vision Healthcare communications
Life Science Vision Healthcare Communications today confirmed to launch India's first education information web portal on deadly Ebola diseases - "www.indiafightebola.com". The new online education resource will be focused to make avai

By Molekule Consulting, Inc.
Molekule consulting, Inc. to sponsor & exhibit at the 2015 Pharma CI Europe Conference & Exhibition. Molekule President, David Alderman, to speak on key competitive intelligence topic

By Creative Biolabs
Antibody has a considerably long history and plays an absolutely essential role through the development process of medicine and biotechnology.

By Venture Planning Group
The pharma companies have a significant opportunity for Ebola virus infection drugs and vaccines, expected to be priced at a premium.

By NuVascular Technologies, Inc.
Textiles and healthcare converge in patented approach to create drug-loaded devices to treat an array of conditions

By Creative Biolabs
Lab-grown tissues could one day provide new treatments for injuries and damage to the joints, including articular cartilage, tendons and ligaments.

By Biozeen
"DAVID can win over Goliath. When business is done the right way, everybody wins," said entrepreneur and founder of Biozeen, a Biopharmaceutical Services Company, at the One Young World Summit 2014.

By Creative Biolabs
A clinical trial demonstrated that patients, and their physicians, are eager to jump into next-era cancer care – custom

By Creative Biolabs
Biotechnology develops technologies and products that help improve our lives and the health of our planet. It is a new prospect of medicine.

By Microlife Agro Sciences
October 16, 2014 Microlife Agro Sciences Contact: Sean Griffin sgriffin@ospreybiotechnics.com 800.553.7785 Media Advisory: Microlife Agro Sciences MicroGain Soil Biofertilizer chosen as Finalist for Bioproduct Innovation of the Year Award held at...

By New Amsterdam Genomics
October 2nd, 2014, (New York, NY) - New Amsterdam Genomics and Prodigo Solutions today announced a partnership that will allow Prodigo Solutions to offer NAG’s revolutionary Genomic sequencing and analysis platform through their digital catalogue,...

By Pathology Diagnostics Ltd
Pathology Diagnostics Ltd is one of the earliest SME recipients of the £180 million Technology Strategy Board (the UK’s Innovation Agency) Biomedical Catalyst funding programme; winning a Biomedical Catalyst feasibility award in the second round.

By Vasuda Capital Management
Vasuda Capital Management, LLC, a Greater Boston-based investment firm, announced that its funds and managed accounts outperformed the S&P 500 index in August 2014 (up 17.6% vs. 3.7%).

By Amyndas Pharmaceuticals
Amyndas Pharmaceuticals SA, the complement therapeutics company, announced that the European Medicines Agency (EMA) has granted AMY-101, a potent complement C3 inhibitor, an Orphan Drug Designation for the treatment of Paroxysmal Nocturnal Hemoglobinuria.

By national algae association
Commercially-minded algae researchers working together with private industry for job training and new business opportunities.

By iGEM
iGEM will host the largest annual gathering of synthetic biologists worldwide at the collegiate division’s Giant Jamboree, October 30 - November 3, 2014
in Boston, Massachusetts.

By UK Shared Business Services Ltd & GATC Biotech Ltd
For three consecutive times GATC Biotech is awarded the DNA sequencing tender by UK Shared Business Services Ltd (UK SBS)

By Mary Ann Liebert, Inc., publishers
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc, (914) 740-2100, kruehle@liebertpub.com Novel Methods May Help Stem Cells Survive Transplantation into Damaged Tissues New Rochelle, NY—Stem cells offer much promise for treating damaged organs and...

By Mary Ann Liebert, Inc., publishers
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc, (914) 740-2100, kruehle@liebertpub.com New Research from Africa on Pharmacomicrobiomics New Rochelle, NY—The Human Microbiome Project (HMP) is a global initiative to identify and characterize the...

By Mary Ann Liebert, Inc., publishers
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc., (914) 740-2100, kruehle@liebertpub.com NIH Turns to Crowdsourcing to Repurpose Drugs: Initial Success Exceeds Expectations New Rochelle, NY–Experimental drugs proven safe but perhaps not sufficiently...

By Information Mapping
With structured HR policies, procedures and other documentation, you can say goodbye to the problems caused by unclear communication. Structured documentation puts you in control of your information.

By Ariel Fernandez Consultancy
Protein structural defects are key players in enzyme catalysis

By Pathology Diagnostics Ltd
Senior technical management staff from Pathology Diagnostics attended the recent DakoLink-UP Scientific Symposium held in York in June 2014.

By Pharma CI Conference
The Pharma CI Asia Conference is the premier event for getting the best information from industry experts (pharmaceutical competitive intelligence), while also providing a unique environment to have meaningful dialogue among peers.

By SMi Group Ltd
As many pharmaceutical companies’ needs for growing their pipelines rise, this is fuelling the increase in partnerships with external groups – academia, biotech and funding organisations.

By SMi Group
Join SMi Group's 2nd annual Lyophilisation forum taking place on 7-8 July, London, and gain insight into current successes and challenges that leading pharmaceutical and biotechnology organisations are facing during their lyophilisation life cycles.

By Jain University
The predicament faced by the world today finds solace in one world sustainability. Multiple crisis emerging in the environment pertaining to climate change, global warming and depletion of resources has triggered a deeper fear of the lapse of the world.

By Transparency Market Research
Orthobiologics Market (Allografts, Viscosupplements, DBM, BMP, Stem Cell and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

By Genetic Engineering and Biotechnology News
Contact: Tamlyn Oliver, Managing Editor, Ph. 914-740-2199, toliver@clinicalomics.com GEN Publishing Introduces “Clinical OMICs” Digital Publication New Rochelle, NY—GEN Publishing recently introduced “Clinical OMICs,”...

By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn, (914) 740-2156, vcohn@liebertpub.com Engineered E.

By Abazyme LLC
SLiCE™, a new cloning platform is now offered by Abazyme Molecular, allows for seamless cloning of DNA fragments with 20 to 50 base pair overlaps. No specialized vectors or restriction enzymes are required to achieve high cloning efficiency.

By Pharma CI Conference
The Best and Largest Conference for the Pharma CI Community is now coming to Asia! Don't Miss Out - Join Your Colleagues at This Highly Anticipated Breakthrough Event!

By Sitemorse Ltd
The Sitemorse quarterly web benchmarks of the global life science sector are always a good indicator of the companies leading the field, because any organisation’s digital communications speak volumes about the way it is managed.

By Calvert Holdings, Inc.
Calvert Holdings, Inc. announced that Michael A. Recny, Ph.D., has been appointed Chief Executive Officer and has been elected a Director of the Company.

By Mary Ann Liebert, Inc., publishers
Mary Ann Liebert, Inc., publishers is proud to announce that it has designated April “Author Appreciation Month” to showcase the stellar work of its authors and increase the discoverability and readership of scholarly articles.

By Sisco Research Laboratories Pvt. Ltd.
Mr. S.K. Agarwal, founder & Managing Director, Sisco Research Laboratories Pvt. Ltd., India, was awarded the Indian Achiever's Award 2014 for Industry Development on 25th February 2014

By Q1 Productions
Partnering with PCORI, Building Effective Industry Alliances, Utilizing Non-Branded Patient Websites Among Discussion Topics

By Triumph Financial Advisors
Discover Triumph Financial Advisors, Inc. the independent financial advisory firm featuring cutting-edge technology, attentive individualized service, business transition assistance and the freedom to choose what's best for you.

By Cancer-Code Corporation
The dawn of a new approach to treating cancer - U.S. Patent No. 8,656,930: “Method and System for Processing Cancer Cell Electrical Signals for Medical Therapy"

By McCarthy Buildiing Companies, Inc.
Designed as one of the most sustainable research facilities in the world, the building is the new home for Venter Institute scientists and staff working to advance genomics

By Osciee Designs
Locally owned web design and marketing firm Osciee Designs has been awarded an RFP to design and develop a website for a new startup company called Bio720.

By Theivasanthi
Indian researchers have identified a novel procedure for nanopowders

By Oxford Instruments
Oxford Instruments, a leading provider of high-technology tools for industry and research has recently acquired Andor.

By Cresset
Guiding Better Decisions in Drug Discovery and Development March 19th, 2014 at British Embassy in Tokyo March 20th, 2014 at British Consulate-General in Osaka

By Kindred Biosciences, Inc.
Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that members of its senior management team will participate in a fireside chat presentation at the 2014 Leerink Global.

By BioCapacity On Demand, LLC
Co-Manufacturing Agreement between BioCapacity On Demand and Medical Coaches Reached

By Able India
BIOINVEST 2014 addressed the critical barriers in the biotech industry today - intellectual capital and investment trends - and provided a platform to discuss these issues and more.



Page:

Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share